AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Ernexa Therapeutics has appointed Dr. Ira S. Winer to its Scientific and Medical Advisory Board. Dr. Winer is a nationally recognized gynecologic oncologist and translational scientist with expertise in women's oncology, immunotherapy, and early-phase clinical development. His appointment further strengthens Ernexa's capabilities as it advances its iMSC platform and lead program, ERNA-101, towards key milestones, including first-in-human trials.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet